← All companies
StageSeries A
Raised$10.22M - $10.7M (sources vary)
Employees57
LocationPortland, OR
About
At Providence, we provide innovative, compassionate care throughout your journey. Our clinical trials offer tomorrow’s care today, with cutting edge research that has made immunotherapy a new standard of cancer care. When it’s cancer, choose Providence.
Product
- Value proposition
- Providing innovative, compassionate cancer care with cutting-edge research, immunotherapy, personalized treatment plans, and robust support across metro-area locations
Founders
- Brad Sorenson
- Eric Marcusson
Categories
cancer careoncologyclinical trialsimmunotherapygenomic sequencingradiation oncologycardio-oncologyintegrative medicinenaturopathymassage therapyacupuncturenurse navigationsupportive care
Products
genomic sequencingimmunotherapy capabilities (CAR T-cell, TIL, high-dose IL-2)targeted therapies (oral and IV chemotherapy)robotic-assisted surgeryMRI-linear accelerator (Gamma Knife Espirit)HDR brachytherapyradiation oncology programclinical trialsgenetic counseling/testingcardio-oncology programintegrative medicine program (naturopathy, massage, acupuncture)
Key features
personalized cancer care plansworld-class immunotherapy capabilitiescomprehensive Radiation Oncology Programgenomic sequencing to guide treatmentrobust clinical trials portfoliogenetic counseling and testingcardio-oncology program to minimize cardiovascular side effectssupportive care with oncology navigators, social workers, dietitians, spiritual careintegrative medicine servicesoncology resource specialists for community navigation
Technologies
genomic sequencingimmunotherapy (CAR T, TIL, high-dose IL-2)robotic-assisted surgeryMRI linear accelerator (Gamma Knife Espirit)HDR brachytherapybiomedical engineering for oncology research
Care settings
hospitalclinicin-personvirtual (some optional resources)
Investors
NGenBill & Melinda Gates FoundationJLabsHana Financial GroupGGV Capital
News
- Providence Innovation Institute · 2025-10-31T00:00:00.000Z
- Impact - Providence Institute for Clinical Innovation · 2025-10-31T00:00:00.000Z
- Advancing cancer care with AI-driven precision · 2026-06-12T05:24:47.000Z
- Providence receives Pfizer-funded Conquer Cancer grant to use revolutionary AI tool to predict cancer mutations · 2026-03-24T09:31:23.000Z
- Replicating clinical trial results through AI: Providence and Microsoft see possibilities through revolutionary new tool · 2025-11-07T23:49:44.000Z
- Microsoft, Providence create AI that unlocks tumor insights - GeekWire · 2025-12-09T00:00:00.000Z


